Geode Capital Management’s Ginkgo Bioworks DNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.5M | Buy |
937,583
+479,154
| +105% | +$5.39M | ﹤0.01% | 2334 |
|
|
2025
Q1 | $2.61M | Buy |
458,429
+21,404
| +5% | +$122K | ﹤0.01% | 2942 |
|
|
2024
Q4 | $4.29M | Buy |
437,025
+20,394
| +5% | +$200K | ﹤0.01% | 2812 |
|
|
2024
Q3 | $3.4M | Buy |
416,631
+33,824
| +9% | +$276K | ﹤0.01% | 2940 |
|
|
2024
Q2 | $5.12M | Sell |
382,807
-164,457
| -30% | -$2.2M | ﹤0.01% | 2704 |
|
|
2024
Q1 | $25.4M | Buy |
547,264
+20,068
| +4% | +$931K | ﹤0.01% | 1778 |
|
|
2023
Q4 | $35.6M | Buy |
527,196
+26,230
| +5% | +$1.77M | ﹤0.01% | 1553 |
|
|
2023
Q3 | $36.3M | Buy |
500,966
+67,724
| +16% | +$4.9M | ﹤0.01% | 1444 |
|
|
2023
Q2 | $32.2M | Buy |
433,242
+91,082
| +27% | +$6.78M | ﹤0.01% | 1537 |
|
|
2023
Q1 | $18.2M | Buy |
342,160
+47,784
| +16% | +$2.54M | ﹤0.01% | 1868 |
|
|
2022
Q4 | $19.9M | Buy |
294,376
+42,624
| +17% | +$2.88M | ﹤0.01% | 1781 |
|
|
2022
Q3 | $31.4M | Sell |
251,752
-48,767
| -16% | -$6.09M | ﹤0.01% | 1422 |
|
|
2022
Q2 | $28.6M | Buy |
300,519
+55,521
| +23% | +$5.29M | ﹤0.01% | 1500 |
|
|
2022
Q1 | $39.5M | Buy |
244,998
+885
| +0.4% | +$143K | ﹤0.01% | 1412 |
|
|
2021
Q4 | $81.1M | Buy |
+244,113
| New | +$81.1M | 0.01% | 950 |
|